Pleural Effusion in Dasatinib-Treated Patients With Chronic Myeloid Leukemia in Chronic Phase: Identification and Management

被引：65

作者：

Cortes, Jorge E. ^{[1
]}

Jimenez, Carlos A. ^{[2
]}

Mauro, Michael J. ^{[3
]}

Geyer, Alex ^{[4
]}

Pinilla-Ibarz, Javier ^{[5
]}

Smith, B. Douglas ^{[6
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, 1515 Holcombe Blvd,Unit 0428, Houston, TX 77030 USA

[2] Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, Houston, TX 77030 USA

[3] Mem Sloan Kettering Canc Ctr, Myeloproliferat Neoplasms Program, 1275 York Ave, New York, NY 10021 USA

[4] Mem Sloan Kettering Canc Ctr, Pulm Serv, 1275 York Ave, New York, NY 10021 USA

[5] H Lee Moffitt Canc Ctr & Res Inst, Malignant Oncol Div, Tampa, FL USA

[6] Johns Hopkins Sidney Kimmel Comprehens Canc, Dept Oncol, Baltimore, MD USA

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2017年 / 17卷 / 02期

关键词：

Adverse events; Algorithms; BCR-ABL1; Fluid retention; Tyrosine kinase inhibitor; ADVERSE EVENTS; IMATINIB; RECOMMENDATIONS; THERAPY; CT;

D O I：

10.1016/j.clml.2016.09.012

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Dasatinib has demonstrated durable clinical responses in patients, both as first-line and subsequent lines of therapy. Dasatinib use can result in pleural effusion in some patients, occurring any time during treatment and commonly characterized as mild to moderate in severity. Early identification of symptoms is essential in the proper management of pleural effusion. Prompt confirmation of diagnosis and management of pleural effusion can minimize morbidity and maximize the ability to preserve long-term clinical benefits with dasatinib. Here, we provide guidance on early identification and management of dasatinib-related pleural effusion.

引用

页码：78 / 82

页数：5

共 20 条

[1] European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013 [J].

Baccarani, Michele ;

Deininger, Michael W. ;

Rosti, Gianantonio ;

Hochhaus, Andreas ;

Soverini, Simona ;

Apperley, Jane F. ;

Cervantes, Francisco ;

Clark, Richard E. ;

Cortes, Jorge E. ;

Guilhot, Francois ;

Hjorth-Hansen, Henrik ;

Hughes, Timothy P. ;

Kantarjian, Hagop M. ;

Kim, Dong-Wook ;

Larson, Richard A. ;

Lipton, Jeffrey H. ;

Mahon, Francois-Xavier ;

Martinelli, Giovanni ;

Mayer, Jiri ;

Mueller, Martin C. ;

Niederwieser, Dietger ;

Pane, Fabrizio ;

Radich, Jerald P. ;

Rousselot, Philippe ;

Saglio, Giuseppe ;

Saussele, Susanne ;

Schiffer, Charles ;

Silver, Richard ;

Simonsson, Bengt ;

Steegmann, Juan-Luis ;

Goldman, John M. ;

Hehlmann, Ruediger .

BLOOD, 2013, 122 (06) :872-884

[2] Lung abnormalities after dasatinib treatment for chronic myeloid leukemia -: A case series [J].

Bergeron, Anne ;

Rea, Delphine ;

Levy, Vincent ;

Picard, Clement ;

Meignin, Veronique ;

Tamburini, Jerome ;

Bruzzoni-Giovanelli, Heriberto ;

Calvo, Fabien ;

Tazi, Abdellatif ;

Rousselot, Philippe .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2007, 176 (08) :814-818

[3] MINIMAL DETECTABLE PLEURAL EFFUSIONS - ROENTGEN PATHOLOGY MODEL [J].

COLLINS, JD ;

FURMANSKI, S ;

STECKEL, RJ ;

BURWELL, D ;

LORBER, P .

RADIOLOGY, 1972, 105 (01) :51-+

[4] Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naive Chronic Myeloid Leukemia Patients Trial [J].

Cortes, Jorge E. ;

Saglio, Giuseppe ;

Kantarjian, Hagop M. ;

Baccarani, Michele ;

Mayer, Jiri ;

Boque, Concepcion ;

Shah, Neil P. ;

Chuah, Charles ;

Casanova, Luis ;

Bradley-Garelik, Brigid ;

Manos, George ;

Hochhaus, Andreas .

JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (20) :2333-U54

[5] Pleural effusions in patients with chronic myeloid leukaemia treated with dasatinib may have an immune-mediated pathogenesis [J].

de lavallade, Hugues ;

Punnialingam, Sinthiya ;

Milojkovic, Dragana ;

Bua, Marco ;

Khorashad, Jamshid S. ;

Gabriel, Ian H. ;

Chaidos, Aristeidis ;

Olavarria, Eduardo ;

Goldman, John M. ;

Apperley, Jane F. ;

Marin, David .

BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 (05) :745-747

[6] Quantification of pleural effusion on CT by simple measurement [J].

Hazlinger, Martin ;

Ctvrtlik, Filip ;

Langova, Katerina ;

Herman, Miroslav .

BIOMEDICAL PAPERS-OLOMOUC, 2014, 158 (01) :107-111

[7] Dasatinib-Related Chylothorax [J].

Huang, Yen-Min ;

Wang, Cheng-Hsu ;

Huang, Jen-Seng ;

Yeh, Kun-Yun ;

Lai, Chien-Hong ;

Wu, Tsung-Han ;

Chang, Pei-Hung ;

Chang, Yueh-Shih ;

Lan, Yu-Jenq .

TURKISH JOURNAL OF HEMATOLOGY, 2015, 32 (01) :68-72

[8] Management of adverse events associated with tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia [J].

Jabbour, E. ;

Deininger, M. ;

Hochhaus, A. .

LEUKEMIA, 2011, 25 (02) :201-210

[9] PLEURAL EFFUSIONS - DIAGNOSTIC SEPARATION OF TRANSUDATES AND EXUDATES [J].

LIGHT, RW ;

LUCHSINGER, PC ;

MACGREGOR, MI ;

BALL, WC .

ANNALS OF INTERNAL MEDICINE, 1972, 77 (04) :507-+

[10]

Light RW, 2008, TXB PLEURAL DIS, P447

← 1 2 →